3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
ConditionInflammatory Arthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.
Eligibility criteria
Qualifiers
Adult patients ≥18 years of age
Hand radiographs performed within the past 3-6 months with imaging results available for analysis
Hand radiographs confirm the presence of bony erosions
Scheduled for a hand MRI as part of their routine clinical care at Mayo Clinic Rochester
Disqualifiers
None
Trial design
Treatments tested in this trial
- oZTEo
Treatment groups
25 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
GE Healthcare
Collaborator
Source ClinicalTrials.gov